Sevoflurane manufacturers

Filters

sevoflurane

Inhalation vapour 100 % - 250 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #40122

sevoflurane

Inhalation solution 250ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Unavailable markets
Algeria , Bahrain , Egypt , Iran , Iraq , Israel , Jordan , Kuwait , Lebanon , Libya , Morocco , Oman , Qatar , Saudi Arabia , Sudan , Syria , Tunisia , United Arab Emirates , Yemen
Manufacturer #8191
A pharmaceutical manufacturer based in Europe that has been active in 10+ countries selling its products in Europe, North America, Asia, MENA, and LATAM for 10+ years. The main therapeutic areas include oncology and immunology. The company's production lines are GMP-compliant. The company possesses branches in Europe and MENA.

sevoflurane

Inhalation solution 100 % - 250 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
EU GMP
Manufacturer #16160

The company is a leading integrated pharmaceutical group specializing in traditional Asian medicine, chemical medicine, and biopharmaceutical products. It operates multiple subsidiaries and is recognized as a top innovator with state-of-the-art research facilities, including national engineering and technology centers. The company collaborates with over 100 research institutions globally and has received prestigious national awards for technological innovation and scientific progress. It maintains high standards of quality with certifications from ICH, FDA, and EDQM, and has passed national GMP authentication. The company focuses on innovation and service, aiming to strengthen its position in chemical pharmaceuticals, traditional Asian medicine, and biopharmaceuticals.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Sevoflurane is a fast-acting inhalable anesthetic agent that is used to induce sleep for patients before surgery. It is marketed as a liquid solution that is turned into vapor and administered to patients orally. Inhalable anesthesia is reportedly associated with lower risks of adverse effects and is more cost-effective than anesthetics that have an intravenous route of administration. And sevoflurane accounts for approximately two-thirds of global inhalable anesthetic drug market share. This is primarily due to its satisfactory effectiveness and lower price. Isoflurane and desflurane – the two primary substitutes in this drug class are typically selected over sevoflurane when there is a need for prolonged maintenance of anesthesia for the patient. Currently, sevoflurane is available in over 120 countries worldwide, with the most popular trade name sevoflurane agent (Ultane) having been used on over 1 billion patients throughout the past 25 years. Its widespread use notwithstanding, most of the global inhalable anesthesia market is split between a limited number of manufacturers and suppliers. The largest suppliers of sevoflurane liquid solutions are AbbVie, Baxter, and Lunan Pharmaceutical. The retail price per 250ml sevoflurane liquid solution is approximately 150-250 EUR.

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.